BDBM511717 (3S)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5- yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5-(piperazin-1-ylmethyl)- 2-azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 22::US11708351, Compound 22

SMILES CC(=O)c1nn(CC(=O)N2C3CC3(CN3CCNCC3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1

InChI Key InChIKey=PBHOGNZIGKKWGP-NPBRFHNESA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 511717   

TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM511717((3S)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5- yl)-1H...)
Affinity DataIC50: <1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM511717((3S)-2-(2-(3-acetyl-5-(2-methylpyrimidin-5- yl)-1H...)
Affinity DataIC50: <1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent